Combination Chemotherapy and Rituximab in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma

NCT00974792 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: pegfilgrastim
BIOLOGICAL: rituximab
DRUG: cyclophosphamide
DRUG: cytarabine
DRUG: doxorubicin hydrochloride
DRUG: etoposide phosphate
DRUG: ifosfamide
DRUG: leucovorin calcium
DRUG: methotrexate
DRUG: vincristine sulfate

Sponsor

Cancer Research UK